Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS
· Delayed Price · Currency is USD
0.0370
-0.0020 (-5.13%)
Jun 29, 2026, 12:05 PM EST
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 272 employees as of December 31, 2025. The number of employees decreased by 234 or -46.25% compared to the previous year.
Employees
272
Change (1Y)
-234
Growth (1Y)
-46.25%
Revenue / Employee
$21,779
Profits / Employee
$92,669
Market Cap
10.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Brainstorm Cell Therapeutics | 19 |
| Reviva Pharmaceuticals Holdings | 14 |
| Synlogic | 1 |
| NKGen Biotech | 26 |
| Zeo ScientifiX | 20 |
| Galera Therapeutics | 3 |
| Inhibitor Therapeutics | 8 |
Adaptimmune Therapeutics News
- 8 months ago - Adaptimmune Announces Changes to Board and Executive Leadership Team - Newsfile Corp
- 9 months ago - Adaptimmune Announces Delisting from Nasdaq - Newsfile Corp
- 11 months ago - Adaptimmune Reports Q2 Financial Results and Provides Business Update - Newsfile Corp
- 11 months ago - Adaptimmune Therapeutics Quarterly report: Q2 2025 - Filings
- 11 months ago - Adaptimmune Therapeutics Earnings release: Q2 2025 - Filings
- 1 year ago - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds - Newsfile Corp
- 1 year ago - Adaptimmune Therapeutics Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Adaptimmune Therapeutics Quarterly report: Q1 2025 - Filings